New model uses infection ‘signatures’ to predict who lives or dies of COVID-19

A critical challenge during the early COVID-19 pandemic was determining whether a patient would survive the infection or die from it. And even though a host of lifesaving therapeutics now spares substantially more lives than four years ago, the art of predicting COVID outcomes remains a matter of scientific pursuit.

This post was originally published on this site